Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Economy & businessNasdaqXenon PharmaceuticalsSyndax PharmaceuticalsIntellia TherapeuticsDufourspitzeCarlsmed, Inc.Kura OncologyAbeona TherapeuticsCandel Therapeutics
Reports
- Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by thewhig.com, chathamdailynews.ca, recorder.ca, standard-freeholder.com, owensoundsuntimes.com, intelligencer.ca, theobserver.ca, elliotlakestandard.ca, simcoereformer.ca, stratfordbeaconherald.com, nugget.ca, thesudburystar.com and 4 more ·
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by recorder.ca, standard-freeholder.com, owensoundsuntimes.com, intelligencer.ca, GlobeNewswire — public companies ·
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — all, daily-tribune.com ·
- ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — public companies ·
- ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — public companies ·
- Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — public companies ·
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — public companies ·
- Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — public companies ·
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — public companies ·
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — all ·
- X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — public companies ·
- Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — public companies ·
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — public companies ·
- Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)Published by manilatimes.net, GlobeNewswire — all ·
- Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — all · en ·
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — all · en ·
- PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — all · en ·
- Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — all · en ·
- Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — all · en ·
- Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire — public companies · en ·
- Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — public companies · en ·
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — public companies · en ·
- Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — public companies · en ·
- Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — public companies · en ·
- Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — public companies · en ·
- Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — public companies · en ·
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — all · en ·
- Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — public companies · en ·
- Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)prnewswire.com · en ·
- Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — public companies · en ·
- Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire — all · en ·